Extracorporeal membrane oxygenation (ECMO) therapy is used to treat certain neonates with respiratory failure. Ultrasound is a useful tool in the ECMO therapy process. Diagnostic medical sonography is used to determine which patients would most benefit from this treatment, and for evaluation of the patient during ECMO therapy. This paper discusses what ECMO therapy is, which patients receive it, and some changes that may be observed sonographically in patients who undergo this treatment.
1. Willett LD, Bolam DL, Goodrich PD, et al. Neonatal extracorporeal membrane oxygenation: an overview and report of a one year experience. Omaha, NE: the Joint Division of Newborn Medicine, University of Nebraska Medical Center and Creighton University, 1990.
2.
2. Ortiz RM, Cilley RE, Bartlett RH. Extracorporeal membrane oxygenation in pediatric respiratory failure. Pediatr Clin N A1987;34:39-46.
3.
3. Cornish JD, Gerstmann DR, Clark RH, et al. Extracorporeal membrane oxygenation and high-frequency oscillatory ventilation: potential therapeutic relationships. Crit Care Med1987;15:831-831.
4.
4. Leuschen MP, Ehrenfried JA, Willett LD, et al. Prostacyclin levels during and following neonatal extracorporeal membrane oxygenation. Omaha, NE: Joint Division of Newborn Medicine, University of Nebraska Medical Center and Creighton University, 1991.
5.
5. Matamoros A, Anderson JC, McConnell J, et al. Neurosonographic findings in infants treated by extracorporeal membrane oxygenation (ECMO). J Child Neurol1989;4: S52-S61.
